Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

Efficacy of EUS-Guided Celiac Plexus Blockade in Chronic Pancreatitis

Study:

A RANDOMIZED, TRIPLE-BLINDED STUDY OF ENDOSCOPIC ULTRASOUND GUIDED CELIAC PLEXUS BLOCKADE (EUS-CPB) WITH BUPIVICAINE AND TRIAMCINOLONE VS. BUPIVICAINE ALONE FOR TREATMENT OF PAIN IN CHRONIC PANCREATITIS

Rationale:

n/a

Purpose:

This is a triple-blind, parallel group, randomized controlled trial to assess the benefit of triamcinolone injection as a therapeutic measure for control of chronic pancreatitis pain. The treatment group will undergo EUS-CPB with bupivicaine plus triamcinolone ("therapeutic block"). There control group will undergo EUS-CPB with bupivicaine alone ("diagnostic block").

Study Status: Recruiting

Recruiting:
Stacey Pallotta 216-445-7488 pallots@ccf.org

Condition Intervention Phase
Chronic Pancreatitis Drug: Triamcinolone
Drug: Bupivicaine alone		 Phase 3

Verified by The Cleveland Clinic April, 2008

Sponsored by: The Cleveland Clinic
Information provided by: The Cleveland Clinic
ClinicalTrials.gov identifier: NCT00658736

Study Type: Interventional

Study Design: Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Placebo Control, Parallel Assignment, Safety/Efficacy Study

Cleveland Clinic Foundation
Cleveland, Ohio 44195
United States

n/a

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.